ACAD

ACADIA PHARMS INC

3 catalysts on file

ACAD

ACADIA PHARMS INC

Approval Confirmed

Nuplazid

71d ago Apr 27, 2026

openFDA verified 15h ago

ACAD

Acadia Pharmaceuticals Inc

Phase 2 AI-extracted

remlifanserin

Alzheimer’s disease psychosis

T-minus 55 days Aug 31, 2026

SEC 8-K verified 14h ago

ACAD

Acadia Pharmaceuticals Inc

Phase 2 AI-extracted

trofinetide

Rett syndrome

T-minus 146 days Nov 30, 2026

SEC 8-K verified 14h ago